In the present study, we found that BIO induced the expression of the cancer stem cell markers EpCAM, CD44, KRT19, and MYC above the levels seen in MeBIO controls without inducing cytotoxicity (Fig. 3B). The gene discussed is EPCAM; the disease is cancer.